LASP1 and osteosarcoma: After the downregulation of LASP1, the resistance of osteosarcoma cells to cisplatin was reduced, the IC50 decreased, and the knockdown of LASP1 could result in the inhibition of the proliferation of osteosarcoma cells (Chang et al., 2022).